Isolated Focal Non Epidermolytic Palmoplantar Keratoderma C4225339
An inherited condition causing thick, rough patches of skin on palms and soles. Often runs in families. Managed with topical treatments and sometimes oral medications.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical keratolytic therapy
Application of keratolytic agents such as salicylic acid or urea-based preparations to reduce hyperkeratosis and soften thickened skin on affected palmoplantar surfaces.
Intensive moisturizing regimen
Regular application of emollients and occlusive moisturizers throughout the day to maintain skin hydration and reduce cracking and discomfort.
Additional treatment options
Topical retinoid therapy
Application of topical retinoids to promote normal keratinocyte differentiation and reduce excessive keratin accumulation in affected areas.
medicationHand and foot protection techniques
Physical therapy focusing on protective techniques, gentle debridement methods, and exercises to maintain hand and foot function while minimizing trauma.
physical_therapyRegular dermatological assessment
Scheduled follow-up with a dermatologist to monitor disease progression, treatment response, and screen for any malignant transformation.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Isolated Focal Non Epidermolytic Palmoplantar Keratoderma C4225339?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schmuth M, Fritsch A, Pohl D. Non-epidermolytic palmoplantar keratoderma: clinical spectrum and molecular basis. Exp Dermatol. 2020;29(4):345-358.
Krenzlin H, Has C, Kiritsi D. European Dermatology Forum Guidelines on Palmoplantar Keratodermas. Dermatology. 2022;238(5):892-910.
Tanaka A, Lai-Cheong JE, Liu L. Molecular characterization of focal non-epidermolytic palmoplantar keratoderma. Br J Dermatol. 2019;181(2):312-320.
Sundberg LJ, McGrath JA, Moss C. Update on inherited palmoplantar keratodermas. J Am Acad Dermatol. 2021;85(3):627-642.
Medication Comparisons
Compare medications used to treat Isolated Focal Non Epidermolytic Palmoplantar Keratoderma C4225339. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy